InnovAge Holding Corp. (INNV) Balance Sheet

The rise in cash from $39.0M in early 2025 to $119.3M in the latest quarter suggests the company has partly repaired its liquidity after a period of tight reserves. However, retained earnings remain deeply negative at -$86.2M, indicating accumulated losses that the recent quarterly profits have not yet erased. The trajectory therefore looks improving but not yet structurally strong, and investors should monitor whether sustained profitability can convert the recent recovery into a durable equity base.

The swings in reported debt, including the drop to $38.4M in 2026Q3 followed by a rebound to $83.9M, may reflect revolving or timing-driven borrowing rather than a fixed long-term capital structure. The current D/E of 0.29 suggests leverage is not a near-term solvency concern, although total liabilities of $273.7M against $563.0M of assets indicate a meaningful obligation base. Investors should monitor the composition of these liabilities, as the reported figures alone do not clarify refinancing terms or maturity profile.

The fact that goodwill has held flat at $142.0M while PP&E has gradually declined from $221.4M to $184.0M suggests the company is not expanding its physical center base at the pace of its earlier investment cycle. Goodwill at roughly a quarter of total assets raises impairment risk if acquired operations underperform, which would be a non-cash hit to equity already carrying a deficit. The declining PP&E trend may indicate reduced capital deployment or depreciation outpacing reinvestment, which warrants further investigation.

A current ratio hovering around 1.0 leaves little margin for error if receivables slow or claims payments accelerate, a risk particularly relevant for a capitated model. The improvement in cash from $39.0M to $119.3M is meaningful, yet the quarter-to-quarter oscillation in the ratio suggests working capital timing is a recurring driver of liquidity. The balance sheet therefore appears adequate for ongoing operations but would likely be tested by any sudden shock to medical cost or payment timing.